On January 25, the new SARS-CoV-2 Test Kit, developed by HymonBio Co., Ltd., was successfully launched and officially passed relevant evaluation of the Shanghai Clinical Laboratory Center. After receiving a “call for help” from a medical laboratory in Wuhan, HymonBio made an emergency production and donated 4,800 SARS-CoV-2 Test Kits in the shortest time possible.
Such good news came one after another: Uzhibo Bio designed and synthesized the new coronavirus vaccine antigen and antibody; Beaver Bio developed a virus extraction kit; Kin Weizhi Bio quickly synthesized and delivered key genes; Spitzer launched an epidemic-prevention-and-control robot; Feiyi Nuo provided online real-time diagnosis for acute and severe cases in epidemic areas…
Post time: Apr-14-2020